Compare Ginkgo Bioworks Holdings Inc (DNA) vs State Street PDR S&P Retail ETF (XRT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs State Street PDR S&P Retail ETF — how do they compare? Ginkgo Bioworks Holdings Inc trades at $13 (market cap $763.64M), while State Street PDR S&P Retail ETF trades at $84.09 (market cap $389.66M). The key difference: Ginkgo Bioworks Holdings Inc is the larger of the two by market cap, and Ginkgo Bioworks Holdings Inc is trading nearer its 52-week high, State Street PDR S&P Retail ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Ginkgo Bioworks Holdings Inc for 7 Days and State Street PDR S&P Retail ETF for 45 Days on average.
| DNA | XRT | |
|---|---|---|
Market Cap | $763.64M | $389.66M |
Volume | 3,204,177 | 4,275,820 |
Sector | Health | Broad Market / Factor |
52-Week High | $15.83 | $92.35 |
52-Week Low | $5.48 | $77.28 |
Typical Hold Time | 7 Days | 45 Days |
Enterprise Value | $865.59M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ginkgo Bioworks (DNA) trades at $11.34, down 1.13% on the day, with a bullish technical signal from moving averages. The company reported a net loss of $312.76 million on $170.16 million revenue for 2025, with negative cash flow. Recent news includes a $17.5 million ARPA-H subcontract for RNA medicine manufacturing, highlighting ongoing strategic initiatives despite financial challenges.
The outlook remains speculative given persistent losses and cash burn, though analyst consensus is divided. Key risks include execution on revenue growth and path to profitability. Upside depends on successful commercialization of its biotech platform and partnerships, but high volatility and fundamental weakness warrant caution for investors.
XRT trades at $83.91, up 1.21% today, with a bullish technical signal but bearish moving averages. Key resistance is at $85, with support at $83. The ETF tracks the retail sector, which faces mixed signals from economic data and consumer sentiment. Recent retail sales showed a rebound in August after a July dip, highlighting sector volatility.
Outlook is cautious due to macroeconomic pressures like inflation and interest rates, which may weigh on consumer spending. Analyst sentiment is mixed, with some expecting underperformance. Risks include economic headwinds and competitive pressures, but the ETF offers diversified retail exposure for investors betting on holiday sales strength.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About State Street PDR S&P Retail ETF
XRT is an equal-weighted ETF that tracks the U.S. retail sector. It provides diversified exposure to apparel, automotive, and online retailers, including well-known names like Amazon, Target, and Costco.
Read more on XRT →
